Why the study?
Few studies have utilized local explainability methods for multimodal deep learning classifiers to provide per-sample insight and evaluate effects of demographic and clinical variables.
A novel local ablation approach for multimodal classifiers reveals the varying importance of EEG, EOG, and EMG across sleep stages and highlights how demographic variables influence model learning.
May inform personalized multimodal sleep staging models; leaves open clinical validation across demographics.
With the growing use of multimodal data for deep learning classification in healthcare research, more studies have begun to present explainability methods for insight into multimodal classifiers. Among these studies, few have utilized local explainability methods, which could provide (1) insight into the classification of each sample and (2) an opportunity to better understand the effects of demographic and clinical variables within datasets (e.g., medication of subjects in electrophysiology data). To the best of our knowledge, this opportunity has not yet been explored within multimodal classification. We present a novel local ablation approach that shows the importance of each modality to the correct classification of each class and explore the effects of demographic and clinical variables upon the classifier. As a use-case, we train a convolutional neural network for automated sleep staging with electroencephalogram (EEG), electrooculogram (EOG), and electromyogram (EMG) data. We find that EEG is the most important modality across most stages, though EOG is particular important for non-rapid eye movement stage 1. Further, we identify significant relationships between the local explanations and subject age, sex, and state of medication which suggest that the classifier learned specific features associated with these variables across multiple modalities and correctly classified samples. Our novel explainability approach has implications for many fields involving multimodal classification. Moreover, our examination of the degree to which demographic and clinical variables may affect classifiers could provide direction for future studies in automated biomarker discovery.
No takes yet. Share an insight, caveat, or question.
Ellis et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: